Tushar Manudhane News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tushar manudhane. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tushar Manudhane Today - Breaking & Trending Today

Cipla promoter group sells 2.53% stake to generate liquidity

Cipla promoter group sells 2.53% stake to generate liquidity
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

Rumana Hamied , Shririn Hamied , Tushar Manudhane , Samina Hamied , Shirin Hamied , Vishal Manchanda , Okasa Pharma , Institutional Research At Systematix , Okasa Pharma Private , Motilal Oswal Financial Services , Cipla Limited , Okasa Pharma Private Limited , Senior Vice President , Institutional Research , Motilal Oswal Financial ,

Growth and margin uptick critical for gains in Divi's Laboratories

Rise in input costs, inventory write-off, and pricing pressures led to a drop in gross margins.

Higher competitive pressures led to cuts in operating profit margins and earnings estimates for FY24 and FY25.

Most brokerages have a neutral or a reduce rating on the stock on account of valuations. ....

Tushar Manudhane , Rahul Jeewani , Divi Lab , Motilal Oswal Research , Phillipcapital Research , Prabhudas Lilladher Research , Motilal Oswal , Naman Bagrecha , Lilladher Research , Oswal Research , Business News , Usiness News India , Ndia Business News , Ndian Economy News , Ndian Financial News ,

Indian pharmacy: Desi pharma pangs continue for India despite dose to fortify pharmacy of the world tag

India, once the pharmacy of the world , is struggling to establish itself as an elite player due to poor manufacturing practices that have led to deaths in some parts of the world, including children. The deaths of children in the West African nation of Gambia in 2022 and the deaths of 65 children in Uzbekistan last year have highlighted the lapse in the quality of drug production in certain India-based pharmaceuticals. ....

United Kingdom , United States , Mansukh Mandaviya , Sun Pharma , Tushar Manudhane , Ranbaxy Laboratories , Drug Administration , European Union , Kilitch Healthcare India Ltd , Motilal Oswal Financial Services Ltd , World Health Organisation , Maiden Pharmaceuticals , India Health , South Asian , Chennai Based Global Pharma , Global Pharma , West African , Marion Biotech , Riemann Labs , New Delhi Based Maiden Pharmaceuticals , Indian Health Ministry , Health Minister Mansukh Mandaviya , Directorate General , Foreign Trade , Indian Pharmacy , Product Recall ,

Courting Cipla: Why giants like Blackstone, Torrent Pharma and Dr Reddy's want to buy the pharma major

Pharma major Cipla has generated considerable interest from private equity players. What makes it such an alluring prospect, and what does the future hold for this storied company? - Issue Date: Oct 29, 2023 ....

United Kingdom , United States , South Africa , New York , South African , Vishal Manchanda , Khwaja Abdul Hamied , Tushar Manudhane , Yusuf Hamied , Yusuf Khwaja Hamied , Nikhil Chopra , Daiichi Sankyo , Umang Vohra , Sun Pharma , Samina Hamied , Manipal Health Enterprises , Cambridge University , Torrent Pharmaceuticals , Systematix Group , Indian Pharmaceutical Alliance , Jb Chemicals Pharmaceuticals , Gilead Sciences , Equity Research Analyst , London School Of Economics Political Science , Sun Pharmaceutical Industries Ltd , Institutional Research At Systematix ,

glenmark: Glenmark closes 3% lower post API arm sale deal

According to analysts, the sale of Glenmark Life could impact the profitability of Glenmark Pharma in FY25 but lower interest payments could offset the impact. ICICI Securities said the company will use the proceeds to clear its outstanding debt of 4,340 crore as of FY23 but the transaction is likely to result in an earnings cut of 5% for FY25. The brokerage has a sell rating on the stock with a price target of 660. ....

Tushar Manudhane , Rohan John , Glenmark Pharma , Aashita Jain , Kunal Randeria , Abdulkader Puranwala , Glenmark Pharmaceuticals , Glenmark Life Sciences , Motilal Oswal Financial Services , Glenmark Life , Api Arm ,